)

Bioxytran (BIXT) investor relations material
Bioxytran Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Remains a clinical-stage pharmaceutical company focused on developing therapeutics for hypoxia and viral diseases, with no product revenue as of June 30, 2025.
Completed recruitment for a Phase 1b/2a COVID-19 trial in India; results expected within 90 days, with a Phase 3 trial contingent on positive outcomes.
U.S. FDA-approved IND for a COVID-19 trial, with initiation planned for Q3 2025; additional INDs for COVID-19 and lung fibrosis treatments in India also expected to start in Q3 2025.
Animal testing of BXT-25 acellular oxygen carrier showed non-toxicity and full recovery in mice; further preclinical studies planned.
Financial highlights
Net loss for the six months ended June 30, 2025, was $1,318,197, compared to $1,222,169 for the same period in 2024.
Net profit of $35,437 for the three months ended June 30, 2025, versus a net loss of $661,647 for the same quarter last year, driven by a reduction in derivative liability.
Accumulated deficit increased to $20,239,366 as of June 30, 2025, from $18,921,169 at December 31, 2024.
Cash balance was $3,144 at June 30, 2025, down from $5,154 at year-end 2024.
Negative working capital of $2,779,627 at June 30, 2025, compared to negative $1,925,488 at December 31, 2024.
Outlook and guidance
Management estimates at least $3.7 million in new funding is needed to support operations and development for the next 15 months.
Plans to raise $2 million via a private placement in spring 2025; ongoing efforts to secure additional capital.
Without additional funding, may need to extend payables, reduce overhead, or scale back business plans.
Next Bioxytran earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage